Riskpilot← Back to searchSign inGet full accessOrthopedia Sweden AB
ABActiveOrg 5591793004Vanadisvägen 13Medical specialists activities · NACE 8622Est. 201822 employees
Revenue 2025
SEK 58,5M
+18% vs 2024
EBITDA margin
2.9%
+216% vs 2024
Equity ratio
34.5%
Financial strength
Net profit 2025
SEK 1,2M
+376% vs 2024
| Revenue | SEK 58,5M | +18% |
| EBITDA | SEK 1,7M | +216% |
| Net profit | SEK 1,2M | +376% |
| Total assets | SEK 11,6M | +27% |
| Equity | SEK 4M | +42% |
| Employees | 22 | — |
Legal name
Orthopedia Sweden AB
Org number
5591793004
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
9 november 2018
Share capital
SEK 50 000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva verksamhet inom hälso- och specialistsjukvård, medicinsk konsultverksamhet, forskning och undervisning samt tjänster inom ovanstående områden även som annan därmed förenlig verksamhet.
Address
Vanadisvägen 13
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 14 136 | 26 057 | 39 743 | 49 655 | 58 500 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 000 | 939 | 1 175 | 536 | 1 694 |
| Depreciation & amort. | −16 | −88 | −88 | −88 | −89 |
| EBIT | 984 | 851 | 1 087 | 448 | 1 605 |
| Net financials | — | −47 | −91 | −82 | −76 |
| Profit before tax | 983 | 805 | 996 | 366 | 1 528 |
| Tax | −209 | −169 | −223 | −116 | −337 |
| Net profit | 774 | 636 | 773 | 250 | 1 191 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 261 | 7 535 | 9 851 | 9 098 | 11 595 |
| Equity | 1 146 | 1 781 | 2 554 | 2 804 | 3 995 |
| Long-term debt | 0 | 1 167 | 1 567 | 1 667 | 1 537 |
| Short-term debt | 3 115 | 4 586 | 5 730 | 4 627 | 6 063 |
| Total debt | 3 115 | 5 753 | 7 297 | 6 294 | 7 600 |
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
20212025
Equity ratio
34.5%
This company
38.2%
Market median
+10% vs market
20212025
Return on equity
29.8%
This company
18.4%
Market median
+62% vs market
20212025
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
20212025
Asset turnover
5.05×
This company
1.12×
Market median
+351% vs market
20212025
Debt / equity
1.90×
This company
0.62×
Market median
-206% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Audit | Audit | 2022 |
| Former (2) | ||
EV Chief Auditor | Chief Auditor | 2020 – 2021 |
MJ Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Orthopedia Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Axel Johannes Nelén | Audit | 0 companies |
| Erik Victor Nilsson Brusewitz | Chief Auditor | 0 companies |
| Maritha Jenny Kumlin | Chief Executive Officer | 0 companies |
| Annelie Sophie Moe | Deputy Board Member | 0 companies |
| Claes Fredrik Svedin | Chairman | 0 companies |
| Lukas Hans Erik Berglund | Board of Directors | 0 companies |